カテゴリー： QYResearch, 世界

世界のトゥレット症候群薬市場 2019年

【英語タイトル】Global Tourette Syndrome Drug Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X16695）・商品コード：DATA909X16695
・発行会社（調査会社）：QYResearch
・発行日：2019年11月22日（※2024年版があります。お問い合わせください）
・ページ数：101
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、トゥレット症候群薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、AZD-5213、CPP-115、デューテトラベナジンER、エコピパム塩酸塩、その他に、用途別には、研究センター、病院、クリニック、その他にセグメント区分し、トゥレット症候群薬の世界市場を分析しました。


・エグゼクティブ・サマリー
・トゥレット症候群薬の世界市場概要
・トゥレット症候群薬の製造コスト構成分析
・トゥレット症候群薬の開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・トゥレット症候群薬の地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・トゥレット症候群薬のセグメント分析（種類別）
（AZD-5213、CPP-115、デューテトラベナジンER、エコピパム塩酸塩、その他）
・トゥレット症候群薬のセグメント分析（用途別）
（研究センター、病院、クリニック、その他）
・トゥレット症候群薬の主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Abide Therapeutics Inc、Catalyst Pharmaceuticals Inc、Neurocrine Biosciences Inc、Psyadon Pharmaceuticals Inc、Reviva Pharmaceuticals Inc、Synchroneuron Inc、Teva Pharmaceutical Industries Ltd、Therapix Biosciences Ltd、）
・トゥレット症候群薬の市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Tourette Syndrome Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Tourette Syndrome Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tourette Syndrome Drug market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Tourette Syndrome Drug in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Tourette Syndrome Drug manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Abide Therapeutics Inc
Catalyst Pharmaceuticals Inc
Neurocrine Biosciences Inc
Psyadon Pharmaceuticals Inc
Reviva Pharmaceuticals Inc
Synchroneuron Inc
Teva Pharmaceutical Industries Ltd
Therapix Biosciences Ltd

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
AZD-5213
CPP-115
Dutetrabenazine ER
Ecopipam Hydrochloride
Others

Segment by Application
Research Center
Hospital
Clinic
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Tourette Syndrome Drug
1.1 Definition of Tourette Syndrome Drug
1.2 Tourette Syndrome Drug Segment by Type
1.2.1 Global Tourette Syndrome Drug Production Growth Rate Comparison by Types (2014-2025)
1.2.2 AZD-5213
1.2.3 CPP-115
1.2.4 Dutetrabenazine ER
1.2.5 Ecopipam Hydrochloride
1.2.6 Others
1.3 Tourette Syndrome Drug Segment by Applications
1.3.1 Global Tourette Syndrome Drug Consumption Comparison by Applications (2014-2025)
1.3.2 Research Center
1.3.3 Hospital
1.3.4 Clinic
1.3.5 Others
1.4 Global Tourette Syndrome Drug Overall Market
1.4.1 Global Tourette Syndrome Drug Revenue (2014-2025)
1.4.2 Global Tourette Syndrome Drug Production (2014-2025)
1.4.3 North America Tourette Syndrome Drug Status and Prospect (2014-2025)
1.4.4 Europe Tourette Syndrome Drug Status and Prospect (2014-2025)
1.4.5 China Tourette Syndrome Drug Status and Prospect (2014-2025)
1.4.6 Japan Tourette Syndrome Drug Status and Prospect (2014-2025)
1.4.7 Southeast Asia Tourette Syndrome Drug Status and Prospect (2014-2025)
1.4.8 India Tourette Syndrome Drug Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Tourette Syndrome Drug
2.3 Manufacturing Process Analysis of Tourette Syndrome Drug
2.4 Industry Chain Structure of Tourette Syndrome Drug

3 Development and Manufacturing Plants Analysis of Tourette Syndrome Drug
3.1 Capacity and Commercial Production Date
3.2 Global Tourette Syndrome Drug Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Tourette Syndrome Drug
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Tourette Syndrome Drug Production and Capacity Analysis
4.2 Tourette Syndrome Drug Revenue Analysis
4.3 Tourette Syndrome Drug Price Analysis
4.4 Market Concentration Degree

5 Tourette Syndrome Drug Regional Market Analysis
5.1 Tourette Syndrome Drug Production by Regions
5.1.1 Global Tourette Syndrome Drug Production by Regions
5.1.2 Global Tourette Syndrome Drug Revenue by Regions
5.2 Tourette Syndrome Drug Consumption by Regions
5.3 North America Tourette Syndrome Drug Market Analysis
5.3.1 North America Tourette Syndrome Drug Production
5.3.2 North America Tourette Syndrome Drug Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Tourette Syndrome Drug Import and Export
5.4 Europe Tourette Syndrome Drug Market Analysis
5.4.1 Europe Tourette Syndrome Drug Production
5.4.2 Europe Tourette Syndrome Drug Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Tourette Syndrome Drug Import and Export
5.5 China Tourette Syndrome Drug Market Analysis
5.5.1 China Tourette Syndrome Drug Production
5.5.2 China Tourette Syndrome Drug Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Tourette Syndrome Drug Import and Export
5.6 Japan Tourette Syndrome Drug Market Analysis
5.6.1 Japan Tourette Syndrome Drug Production
5.6.2 Japan Tourette Syndrome Drug Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Tourette Syndrome Drug Import and Export
5.7 Southeast Asia Tourette Syndrome Drug Market Analysis
5.7.1 Southeast Asia Tourette Syndrome Drug Production
5.7.2 Southeast Asia Tourette Syndrome Drug Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Tourette Syndrome Drug Import and Export
5.8 India Tourette Syndrome Drug Market Analysis
5.8.1 India Tourette Syndrome Drug Production
5.8.2 India Tourette Syndrome Drug Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Tourette Syndrome Drug Import and Export

6 Tourette Syndrome Drug Segment Market Analysis (by Type)
6.1 Global Tourette Syndrome Drug Production by Type
6.2 Global Tourette Syndrome Drug Revenue by Type
6.3 Tourette Syndrome Drug Price by Type

7 Tourette Syndrome Drug Segment Market Analysis (by Application)
7.1 Global Tourette Syndrome Drug Consumption by Application
7.2 Global Tourette Syndrome Drug Consumption Market Share by Application (2014-2019)

8 Tourette Syndrome Drug Major Manufacturers Analysis
8.1 Abide Therapeutics Inc
8.1.1 Abide Therapeutics Inc Tourette Syndrome Drug Production Sites and Area Served
8.1.2 Abide Therapeutics Inc Product Introduction, Application and Specification
8.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Catalyst Pharmaceuticals Inc
8.2.1 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Production Sites and Area Served
8.2.2 Catalyst Pharmaceuticals Inc Product Introduction, Application and Specification
8.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Neurocrine Biosciences Inc
8.3.1 Neurocrine Biosciences Inc Tourette Syndrome Drug Production Sites and Area Served
8.3.2 Neurocrine Biosciences Inc Product Introduction, Application and Specification
8.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Psyadon Pharmaceuticals Inc
8.4.1 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Production Sites and Area Served
8.4.2 Psyadon Pharmaceuticals Inc Product Introduction, Application and Specification
8.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Reviva Pharmaceuticals Inc
8.5.1 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Production Sites and Area Served
8.5.2 Reviva Pharmaceuticals Inc Product Introduction, Application and Specification
8.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Synchroneuron Inc
8.6.1 Synchroneuron Inc Tourette Syndrome Drug Production Sites and Area Served
8.6.2 Synchroneuron Inc Product Introduction, Application and Specification
8.6.3 Synchroneuron Inc Tourette Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Teva Pharmaceutical Industries Ltd
8.7.1 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Production Sites and Area Served
8.7.2 Teva Pharmaceutical Industries Ltd Product Introduction, Application and Specification
8.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Therapix Biosciences Ltd
8.8.1 Therapix Biosciences Ltd Tourette Syndrome Drug Production Sites and Area Served
8.8.2 Therapix Biosciences Ltd Product Introduction, Application and Specification
8.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served

9 Development Trend of Analysis of Tourette Syndrome Drug Market
9.1 Global Tourette Syndrome Drug Market Trend Analysis
9.1.1 Global Tourette Syndrome Drug Market Size (Volume and Value) Forecast 2019-2025
9.2 Tourette Syndrome Drug Regional Market Trend
9.2.1 North America Tourette Syndrome Drug Forecast 2019-2025
9.2.2 Europe Tourette Syndrome Drug Forecast 2019-2025
9.2.3 China Tourette Syndrome Drug Forecast 2019-2025
9.2.4 Japan Tourette Syndrome Drug Forecast 2019-2025
9.2.5 Southeast Asia Tourette Syndrome Drug Forecast 2019-2025
9.2.6 India Tourette Syndrome Drug Forecast 2019-2025
9.3 Tourette Syndrome Drug Market Trend (Product Type)
9.4 Tourette Syndrome Drug Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Tourette Syndrome Drug Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Tourette Syndrome Drug
Table Global Tourette Syndrome Drug Production (K Pcs) Growth Rate Comparison by Types (2014-2025)
Figure Global Tourette Syndrome Drug Production Market Share by Types in 2018
Figure AZD-5213 Product Picture
Figure CPP-115 Product Picture
Figure Dutetrabenazine ER Product Picture
Figure Ecopipam Hydrochloride Product Picture
Figure Others Product Picture
Table Global Tourette Syndrome Drug Consumption (K Pcs) Comparison by Applications (2014-2025)
Figure Global Tourette Syndrome Drug Consumption Market Share by Applications in 2018
Figure Research Center
Figure Hospital
Figure Clinic
Figure Others
Figure Global Tourette Syndrome Drug Revenue (Million USD) (2014-2025)
Figure Global Tourette Syndrome Drug Production (K Pcs) (2014-2025)
Figure North America Tourette Syndrome Drug Market Size (Million USD) (2014-2025)
Figure Europe Tourette Syndrome Drug Market Size (Million USD) (2014-2025)
Figure China Tourette Syndrome Drug Market Size (Million USD) (2014-2025)
Figure Japan Tourette Syndrome Drug Market Size (Million USD) (2014-2025)
Figure Southeast Asia Tourette Syndrome Drug Market Size (Million USD) (2014-2025)
Figure India Tourette Syndrome Drug Market Size (Million USD) (2014-2025)
Table Tourette Syndrome Drug Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Tourette Syndrome Drug in 2018
Figure Manufacturing Process Analysis of Tourette Syndrome Drug
Figure Industry Chain Structure of Tourette Syndrome Drug
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Tourette Syndrome Drug Manufacturing Plants Distribution
Table Tourette Syndrome Drug Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Tourette Syndrome Drug Capacity (K Pcs) of Major Manufacturers (2014-2019)
Table Tourette Syndrome Drug Production (K Pcs) of Major Manufacturers (2014-2019)
Table Tourette Syndrome Drug Production Market Share of Major Manufacturers (2014-2019)
Figure Tourette Syndrome Drug Production Share by Manufacturers in 2018
Table Tourette Syndrome Drug Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Tourette Syndrome Drug Revenue Market Share of Major Manufacturers (2014-2019)
Figure Tourette Syndrome Drug Revenue Share by Manufacturers in 2018
Table Tourette Syndrome Drug Average Price (USD/Pcs) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Tourette Syndrome Drug Production by Regions 2014-2019 (K Pcs)
Table Global Tourette Syndrome Drug Production Market Share by Regions 2014-2019
Figure Global Tourette Syndrome Drug Production Market Share by Regions in 2018
Table Global Tourette Syndrome Drug Revenue by Regions 2014-2019 (Million USD)
Table Global Tourette Syndrome Drug Revenue Market Share by Regions 2014-2019
Figure Global Tourette Syndrome Drug Revenue Market Share by Regions in 2018
Table Global Tourette Syndrome Drug Consumption by Regions 2014-2019 (K Pcs)
Table Global Tourette Syndrome Drug Consumption Market Share by Regions 2014-2019
Figure North America Tourette Syndrome Drug Production Growth Rate 2014-2019 (K Pcs)
Figure North America Tourette Syndrome Drug Revenue Growth Rate 2014-2019 (Million USD)
Table North America Tourette Syndrome Drug Production, Consumption Import and Export (K Pcs)
Figure Europe Tourette Syndrome Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Europe Tourette Syndrome Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Tourette Syndrome Drug Production, Consumption Import and Export (K Pcs)
Figure China Tourette Syndrome Drug Production Growth Rate 2014-2019 (K Pcs)
Figure China Tourette Syndrome Drug Revenue Growth Rate 2014-2019 (Million USD)
Table China Tourette Syndrome Drug Production, Consumption Import and Export (K Pcs)
Figure Japan Tourette Syndrome Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Japan Tourette Syndrome Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Tourette Syndrome Drug Production, Consumption Import and Export (K Pcs)
Figure Southeast Asia Tourette Syndrome Drug Production Growth Rate 2014-2019 (K Pcs)
Figure Southeast Asia Tourette Syndrome Drug Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Tourette Syndrome Drug Production, Consumption Import and Export (K Pcs)
Figure India Tourette Syndrome Drug Production Growth Rate 2014-2019 (K Pcs)
Figure India Tourette Syndrome Drug Revenue Growth Rate 2014-2019 (Million USD)
Table India Tourette Syndrome Drug Production, Consumption Import and Export (K Pcs)
Figure Global Consumption Tourette Syndrome Drug Market Share by Application (2014-2019)
Figure Global Value (Consumption) Tourette Syndrome Drug Market Share by Application (2014-2019)
Table Abide Therapeutics Inc Tourette Syndrome Drug Production Sites and Area Served
Table Abide Therapeutics Inc Tourette Syndrome Drug Product Introduction, Application and Specification
Table Abide Therapeutics Inc Tourette Syndrome Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Abide Therapeutics Inc Tourette Syndrome Drug Production Growth Rate (2014-2019)
Table Abide Therapeutics Inc Tourette Syndrome Drug Production Market Share (2014-2019)
Figure Abide Therapeutics Inc Tourette Syndrome Drug Revenue Market Share (2014-2019)
Table Abide Therapeutics Inc Tourette Syndrome Drug Main Business and Markets Served
Table Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Production Sites and Area Served
Table Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Product Introduction, Application and Specification
Table Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Production Growth Rate (2014-2019)
Table Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Production Market Share (2014-2019)
Figure Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Revenue Market Share (2014-2019)
Table Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Main Business and Markets Served
Table Neurocrine Biosciences Inc Tourette Syndrome Drug Production Sites and Area Served
Table Neurocrine Biosciences Inc Tourette Syndrome Drug Product Introduction, Application and Specification
Table Neurocrine Biosciences Inc Tourette Syndrome Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Neurocrine Biosciences Inc Tourette Syndrome Drug Production Growth Rate (2014-2019)
Table Neurocrine Biosciences Inc Tourette Syndrome Drug Production Market Share (2014-2019)
Figure Neurocrine Biosciences Inc Tourette Syndrome Drug Revenue Market Share (2014-2019)
Table Neurocrine Biosciences Inc Tourette Syndrome Drug Main Business and Markets Served
Table Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Production Sites and Area Served
Table Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Product Introduction, Application and Specification
Table Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Production Growth Rate (2014-2019)
Table Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Production Market Share (2014-2019)
Figure Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Revenue Market Share (2014-2019)
Table Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Main Business and Markets Served
Table Reviva Pharmaceuticals Inc Tourette Syndrome Drug Production Sites and Area Served
Table Reviva Pharmaceuticals Inc Tourette Syndrome Drug Product Introduction, Application and Specification
Table Reviva Pharmaceuticals Inc Tourette Syndrome Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Reviva Pharmaceuticals Inc Tourette Syndrome Drug Production Growth Rate (2014-2019)
Table Reviva Pharmaceuticals Inc Tourette Syndrome Drug Production Market Share (2014-2019)
Figure Reviva Pharmaceuticals Inc Tourette Syndrome Drug Revenue Market Share (2014-2019)
Table Reviva Pharmaceuticals Inc Tourette Syndrome Drug Main Business and Markets Served
Table Synchroneuron Inc Tourette Syndrome Drug Production Sites and Area Served
Table Synchroneuron Inc Tourette Syndrome Drug Product Introduction, Application and Specification
Table Synchroneuron Inc Tourette Syndrome Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Synchroneuron Inc Tourette Syndrome Drug Production Growth Rate (2014-2019)
Table Synchroneuron Inc Tourette Syndrome Drug Production Market Share (2014-2019)
Figure Synchroneuron Inc Tourette Syndrome Drug Revenue Market Share (2014-2019)
Table Synchroneuron Inc Tourette Syndrome Drug Main Business and Markets Served
Table Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Production Sites and Area Served
Table Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Product Introduction, Application and Specification
Table Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Production Growth Rate (2014-2019)
Table Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Production Market Share (2014-2019)
Figure Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Revenue Market Share (2014-2019)
Table Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Main Business and Markets Served
Table Therapix Biosciences Ltd Tourette Syndrome Drug Production Sites and Area Served
Table Therapix Biosciences Ltd Tourette Syndrome Drug Product Introduction, Application and Specification
Table Therapix Biosciences Ltd Tourette Syndrome Drug Production (K Pcs), Revenue (Million USD), Ex-factory Price (USD/Pcs) and Gross Margin (2014-2019)
Table Therapix Biosciences Ltd Tourette Syndrome Drug Production Growth Rate (2014-2019)
Table Therapix Biosciences Ltd Tourette Syndrome Drug Production Market Share (2014-2019)
Figure Therapix Biosciences Ltd Tourette Syndrome Drug Revenue Market Share (2014-2019)
Table Therapix Biosciences Ltd Tourette Syndrome Drug Main Business and Markets Served
Figure Global Tourette Syndrome Drug Production (K Pcs) Growth Rate Forecast 2019-2025
Figure Global Tourette Syndrome Drug Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Tourette Syndrome Drug Sales Price (USD/Pcs) Forecast 2019-2025
Figure North America Tourette Syndrome Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure North America Tourette Syndrome Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Tourette Syndrome Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Europe Tourette Syndrome Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Tourette Syndrome Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure China Tourette Syndrome Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Tourette Syndrome Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Japan Tourette Syndrome Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Tourette Syndrome Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Tourette Syndrome Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Tourette Syndrome Drug Production Growth Rate Forecast 2019-2025 (K Pcs)
Figure India Tourette Syndrome Drug Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (K Pcs) of Tourette Syndrome Drug by Type (2019-2025)
Table Global Consumption (K Pcs) of Tourette Syndrome Drug by Application (2019-2025)
Table Tourette Syndrome Drug Distributors List
Table Tourette Syndrome Drug Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Abide Therapeutics Inc、Catalyst Pharmaceuticals Inc、Neurocrine Biosciences Inc、Psyadon Pharmaceuticals Inc、Reviva Pharmaceuticals Inc、Synchroneuron Inc、Teva Pharmaceutical Industries Ltd、Therapix Biosciences Ltd、

★調査レポート[世界のトゥレット症候群薬市場 2019年] (コード：DATA909X16695)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のトゥレット症候群薬市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の非定型溶血性尿毒症症候群薬市場 2019年
    DATA909X03808 / QYResearch / 2019年11月15日 / ※本調査レポートは、非定型溶血性尿毒症症候群薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ALN-CC5、CCX-168、ET-006、ETR-001、Mubodina、OMS-72、その他に、用途別には、クリニック、病院、その他にセグメント区分し、非定型溶血性尿毒症症候群薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・非定型溶血性尿毒症症候群薬の世界市場概要 ・非定型溶血性尿毒症症候群薬の製造コスト構成分析 ・非定型溶血性尿毒症症候群薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・非定型溶血性尿毒症症候群薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・非定型溶血性尿毒症症候群薬のセグメント分析（種類別） （ALN-CC5、CCX-168、ET-006、ETR-001、Mubodina、OMS-72、その他）...The global Atypical Hemolytic Uremic Syndrome Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Atypical Hemolytic Uremic Syndrome Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Atypical Hemolytic Uremic Syndrome Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Atypical Hemolytic Uremic Syndrome Drug in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の便秘薬による過敏性腸症候群市場 2019年
    DATA909X10087 / QYResearch / 2019年11月20日 / ※本調査レポートは、便秘薬による過敏性腸症候群の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、ルビプロストン、リナクロチド、覚せい剤下剤、浸透圧性下剤、その他に、用途別には、病院、診療所、その他にセグメント区分し、便秘薬による過敏性腸症候群の世界市場を分析しました。 ・エグゼクティブ・サマリー ・便秘薬による過敏性腸症候群の世界市場概要 ・便秘薬による過敏性腸症候群の製造コスト構成分析 ・便秘薬による過敏性腸症候群の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・便秘薬による過敏性腸症候群の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・便秘薬による過敏性腸症候群のセグメント分析（種類別） （ルビプロストン、リナクロチド、覚せい剤下剤、浸透圧性下剤、その他）...The global Irritable Bowel Syndrome with Constipation Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Irritable Bowel Syndrome with Constipation Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Irritable Bowel Syndrome with Constipation Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Irritable Bowel Syndrome with Constipation Drugs in North America, Europe, China,...
  • 世界の下痢を伴う過敏性腸症候群（IBS-D）薬市場 2019年
    DATA909X10088 / QYResearch / 2019年11月20日 / ※本調査レポートは、下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、序文、エルキサドリン、アロセトロン、リファキシミン、ロペラミド、ジフェノキシレート+アトロピン、ジシクロミン及びヒヨスチアミンに、用途別には、病院、診療所、その他にセグメント区分し、下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・下痢を伴う過敏性腸症候群（IBS-D）薬の世界市場概要 ・下痢を伴う過敏性腸症候群（IBS-D）薬の製造コスト構成分析 ・下痢を伴う過敏性腸症候群（IBS-D）薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・下痢を伴う過敏性腸症候群（IBS-D）薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・下痢を伴う過敏性腸症候群（IBS-D）薬のセグメント分析（種類別） （序文、エルキサドリン、アロセトロン、リファキシミン、ロペラミド、ジフェノキシレート+アトロピン、ジシクロミン及びヒヨスチアミン）...The global Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Irritable Bowel Syndrome with Diarrhea (IBS-D) Drugs in...
  • 世界のレット症候群治療薬市場 2019年
    DATA909X14357 / QYResearch / 2019年11月20日 / ※本調査レポートは、レット症候群治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、BHV-5000、ブリオスタチン-1、CPT-157633、ELX-02、その他に、用途別には、病院、診療所、その他にセグメント区分し、レット症候群治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・レット症候群治療薬の世界市場概要 ・レット症候群治療薬の製造コスト構成分析 ・レット症候群治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・レット症候群治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・レット症候群治療薬のセグメント分析（種類別） （BHV-5000、ブリオスタチン-1、CPT-157633、ELX-02、その他）...The global Rett Syndrome Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Rett Syndrome Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Rett Syndrome Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Rett Syndrome Therapeutics in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 多嚢胞性卵巣症候群治療の世界市場：規模・現状・予測2019-2025
    DATA909X18844 / QYResearch / 2019年11月25日 / ※当調査レポートでは、多嚢胞性卵巣症候群治療の世界市場について調査・分析し、多嚢胞性卵巣症候群治療の世界市場規模、市場動向、主要企業別マーケットシェア、主要地域別市場規模、企業プロフィールなどの情報をまとめました。また、セグメント分析では、種類別（経口避妊薬、インスリン抵抗性改善薬、抗うつ薬、オルニチンデカルボキシラーゼ阻害薬、アロマターゼ阻害薬、利尿薬）、用途別（病院薬局、ドラッグストア）、地域別（北米、ヨーロッパ、中国、日本国内、東南アジア、インド、中南米）に区分して市場規模を算出しました。 ・レポートの概要 ・世界の多嚢胞性卵巣症候群治療市場動向 ・主要企業別マーケットシェア ・多嚢胞性卵巣症候群治療の種類別市場規模2014-2019 （経口避妊薬、インスリン抵抗性改善薬、抗うつ薬、オルニチンデカルボキシラーゼ阻害薬、アロマターゼ阻害薬、利尿薬） ・多嚢胞性卵巣症候群治療の用途別市場規模2014-2019 （病院薬局、ドラッグストア） ・多嚢胞性卵巣症候群治療の北米市場：主要企業・種類別/用途別市場規模 ・多嚢胞性卵巣症候群治療のヨーロッパ市場：主要企業・種類別/用途別市場規模...Polycystic Ovary Syndrome Treatment means treatment of  a common hormonal endocrine disorder that affects women of child bearing age (15 to 49 years). This disease is characterized by the formation of cysts on the ovaries leading to an insufficiency of the ovulation initiating hormone in the female body.In 2018, the global Polycystic Ovary Syndrome Treatment market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Polycystic Ovary Syndrome Treatment status, future forecast, growth opportunity, key market and...
  • 世界の急性呼吸窮迫症候群(ARDS)治療薬市場 2019年
    DATA909X02949 / QYResearch / 2019年11月15日 / ※本調査レポートは、急性呼吸窮迫症候群(ARDS)治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、メチルプレドニゾロン、ヒドロコルチゾン、注射用子牛肺サーファクタント、その他に、用途別には、入院患者、外来患者にセグメント区分し、急性呼吸窮迫症候群(ARDS)治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・急性呼吸窮迫症候群(ARDS)治療薬の世界市場概要 ・急性呼吸窮迫症候群(ARDS)治療薬の製造コスト構成分析 ・急性呼吸窮迫症候群(ARDS)治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・急性呼吸窮迫症候群(ARDS)治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・急性呼吸窮迫症候群(ARDS)治療薬のセグメント分析（種類別） （メチルプレドニゾロン、ヒドロコルチゾン、注射用子牛肺サーファクタント、その他）...The global Acute Respiratory Distress Syndrome Therapeutics market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Acute Respiratory Distress Syndrome Therapeutics volume and value at global level, regional level and company level. From a global perspective, this report represents overall Acute Respiratory Distress Syndrome Therapeutics market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Acute Respiratory Distress Syndrome Therapeutics in North America, Europe, China, Japan, Southeast Asia and...
  • 世界の多嚢胞性卵巣症候群（PCOS）治療薬市場 2019年
    DATA909X13285 / QYResearch / 2019年11月20日 / ※本調査レポートは、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬に、用途別には、病院、クリニックにセグメント区分し、多嚢胞性卵巣症候群（PCOS）治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・多嚢胞性卵巣症候群（PCOS）治療薬の世界市場概要 ・多嚢胞性卵巣症候群（PCOS）治療薬の製造コスト構成分析 ・多嚢胞性卵巣症候群（PCOS）治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・多嚢胞性卵巣症候群（PCOS）治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・多嚢胞性卵巣症候群（PCOS）治療薬のセグメント分析（種類別） （経口避妊薬、抗炎症薬、インスリン抵抗性改善薬、抗高血圧薬、抗肥満薬）...The global Polycystic Ovary Syndrome (PCOS) Drugs market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polycystic Ovary Syndrome (PCOS) Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polycystic Ovary Syndrome (PCOS) Drugs market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Polycystic Ovary Syndrome (PCOS) Drugs in North America, Europe, China, Japan, Southeast Asia and...

    • ◆H&Iグローバルリサーチのお客様（例）◆